Trial Condition(s):
Testosterone
Association between the Prevalence of cardiovascular risk factors and new use of testosterone
Bayer Identifier:
19547
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Not Yet Recruiting
Trial Purpose
We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resulting in overestimation of the cardiovascular risk associated with testosterone when compared to a healthier population not taking testosterone
Inclusion Criteria
- All male individuals in the source population with a first testosterone use during the study period will be included as cases. The date of the GP consultation associated with the first testosterone prescription will be designated as the index day.
Exclusion Criteria
- Patients of less than 18 years on the index day, with less than 2-year contribution to the CPRD-HES link before the index day, or with use of testosterone before the study period will be excluded from the group of cases.
Trial Summary
Enrollment Goal
23000
Trial Dates
Phase
4
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No
Where to Participate
Loading...
Locations
Status
| Locations | Status | |
|---|---|---|
Locations Many Locations Berlin, Germany | Status Not yet recruiting | Contact Us: E-mail: [email protected] Phone: (+) 1-888-8422937 |
For details, please refer to trial results
Additional Information
Not Available
Copyright © Bayer
Powered by
